Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Filgrastim For The Period From 01.04.2026 To 31.03.2028 (plus An Extension Option Of 1x12 Months). Filgrastim 2026-08-15
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Estriol (excl. Dafo. Vcr) Atc G03cd01 F. D. Z. 01.04.26 - 31.03.28 (plus Extension Option 1x12 Months) 2026-08-15
Germany Open House Drug Discount Agreements For The Active Ingredient Carbamazepine, Atc N03af01 2026-08-15
Germany Open House Drug Discount Agreements For The Active Ingredient Palonosetron, Atc A04aa05 2026-08-15
Germany Open House Drug Discount Agreements For The Active Ingredient Haloperidol, Atc N05ad01 2026-08-15
Germany Open House Drug Discount Agreements For The Active Ingredients Norethisterone And Estrogen, Atc G03fa01 2026-08-15
Germany Open House Drug Discount Agreements For The Active Ingredient Botulinum Toxin Type A, Atc M03ax21 2026-08-15
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Ciclesonid For The Period 01.04.2026 - 31.03.2027 (plus Extension Option For 1x12 Months). Ciclesonid 2026-08-15
Germany Open House Drug Discount Agreements For The Active Ingredient Testosterone, Atc G03ba03 2026-08-15
Germany Open House Drug Discount Agreements For The Active Ingredient Mesalazine, Atc A07ec02 2026-08-15
Whats app